1. Recently we reported decreased activities of two mitochondrial marker enzymes (citrate synthase and cytochrome c oxidase) in skeletal muscle from a rat model of critical illness (zymosan injection). In the present study we investigated (i) whether these decreases in enzyme activity reflect a reduction in mitochondrial content and (ii) whether this potential reduction in mitochondrial content was the result of decreased mitochondrial protein synthesis rates. 2. Mitochondria1 protein content was calculated from the activities of cytochrome c oxidase in wholemuscle homogenates and purified mitochondria. Synthesis rates of mitochondrial protein in vivo were studied by measuring the incorporation of C3H]phenylalanine into mitochondrial protein using the flooding dose technique. 3. Mitochondrial protein content was reduced to 54% of that measured in the pair-fed rats and to 71% of that measured in control rats fed ad libitum 2days after the zymosan treatment. The decreased mitochondrial protein content observed 2 days after zymosan challenge was preceded by a reduced rate of synthesis of mitochondrial protein 16 h after treatment. Both changes were of greater magnitude than the general muscle wasting and the decreased rate of synthesis of mixed protein observed in the zymosantreated rats. 4. We conclude that the acute phase of critical illness in zymosan-treated rats is characterized by a substantial reduction in muscle mitochondria that is at least in part caused by a decreased rate of synthesis of mitochondrial protein. This derangement in mitochondrial protein metabolism may be related to the impaired muscle function observed during and after critical illness.
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INTRODUCTION
Patients recovering from severe catabolic diseases (e.g. major surgery, sepsis or burn injury) often experience muscle weakness and increased fatiguability, sometimes for months after discharge from hospital. A reduction in both muscle force and endurance performance has been suggested to contribute to this general feeling of tiredness and 475 fatigue [l-31. Studies in the field of exercise physiology have shown that muscle endurance performance is related to mitochondrial content [4] . Decreased activities of mitochondrial marker enzymes, suggesting a reduction in mitochondrial content, have been reported in skeletal muscle from an animal model of critical illness [S] and in intensive care unit patients [6] .
In the present study zymosan-injected rats were used as a model for severe catabolic stress to study the derangement in mitochondrial protein metabolism in skeletal muscle. Zymosan is an extract of yeast cell wall and is a potent activator of the alternative complement system and of macrophages. When injected into rats it leads to an acute phase of critical illness, most likely due to a systemic inflammatory response, followed by a prolonged recovery phase [7] . The model is characterized by many features observed in critically ill patients . In the present study we used this model because of the muscle wasting that occurs during the acute phase [7] and the decreased activities of citrate synthase and cytochrome c oxidase (mitochondrial marker enzymes) found in skeletal muscle during both the acute phase and recovery [S]. These results may imply that the mitochondrial content is reduced in skeletal muscle or may reflect a specific loss of activity of these enzymes. The latter possibility should lead to a decrease in the activity of the enzymes in purified mitochondria. We therefore measured cytochrome c oxidase activities in wholemuscle homogenates and in purified mitochondria, and used these activities to estimate mitochondrial protein content in skeletal muscle.
Loss of mitochondrial protein can be the result of either enhanced protein degradation rates, decreased protein synthesis rates or a combination of both. Unfortunately, no method is currently available to estimate mitochondrial protein degradation in uiuo.
In the present study, we measured mitochondrial protein synthesis rates in uiuo to elucidate a potential mechanism for a decreased mitochondrial content in skeletal muscle from zymosan-treated rats. In addition to mitochondrial protein, other subcellular protein fractions (soluble and myofibrillar protein) were obtained during the fractionation procedure.
Protein synthesis rates of all protein fractions were measured to investigate whether the reduction in muscle protein synthesis rates is a general phenomenon or varies between fractions.
METHODS
Male Lewis rats weighing approximately 200-300g were obtained from the animal facilities of the University of Limburg. Rats were individually housed in grill-bottom cages and were allowed to acclimatize for at least 1 week. During this period rats were kept in a controlled environment (12 h light-dark cycle, 20-21°C and 50-60% humidity) and had free access to water and food (SMRA, Hope Farms, The Netherlands) containing (w/w) approximately 28% protein, 7% fat, 54% carbohydrates, 4% fibres and 7% minerals with a trace element and vitamin supplement. Food intake and body weight were measured daily. All the experiments were approved by the Animal Experimental Committee of the University of Limburg.
The zymosan-treated rats were injected intraperitoneally with 50mg of zymosan suspended in 2ml of sterile liquid paraffin per lOOg of body weight as described previously [7] . Zymosan treatment decreases food intake during the first 2 days after injection and, therefore, control rats were pair fed. To mimic as closely as possible the pattern of food intake in zymosan-treated rats, pair feeding was performed three times a day [7] . The pair-fed control rats were injected with paraffin only (2ml per l00g of body weight). A control group with free access to food but not injected with paraffin was also included in the studies.
In a previous study, synthesis rates of mixed protein in skeletal muscle were found to be decreased 16h after zymosan treatment and to have returned to the values of pair-fed animals after 2days [7] . In addition, the greatest reduction in the activity of cytochrome c oxidase occurred after 2days [S] . As a decrease in synthesis rates should precede the fall in enzyme activity, mitochondrial protein synthesis rates were measured here 16 h after zymosan treatment. Mitochondrial protein content was measured 16 h (same rats as synthesis rates) and 2 days (additional experiment) after treatment. In addition, muscle specimens were investigated by means of electron microscopy in another set of rats to obtain an impression of the morphology of muscle mitochondria.
Subcellular fractionation
Purification of muscle mitochondria was based on a procedure described previously [14, 151 . After thawing muscle tissue in ice-cold SET buffer (0.25 mol/l sucrose, 2 mmol/l EDTA, 10 mmol/l Tris-HCI; pH 7.4) the tissue was carefully dissected free of visible fat and connective tissue. After blotting, mincing and weighing the muscle, a 5-7% muscle homogenate was prepared in SET buffer using a motor-driven Teflon pestle and a Potter-Elvejhem tube. Samples for measurement of mixed protein were taken from this homogenate. Subsequently, the homogenate was centrifuged for 10min at 600g, to separate the nuclear-myofibrillar fraction from mitochondrial, microsomal and soluble constituents. The supernatant was centrifuged for 10min at 7000g to yield a mitochondrial pellet. This pellet was washed twice with 25ml of suspension buffer (100mmol/l potassium chloride, 1 mmol/l magnesium chloride, 0.2 mmol/l EDTA, 0.2 mmol/l ATP, 50 mmol/l Tris-HC1; pH 7.4). The final mitochondrial suspension was used for measurements.
The supernatant obtained after centrifugation at 7000g was subsequently centrifuged for 60min at 100 00Og to precipitate small particles, giving rise to a supernatant containing soluble protein. The nuclear-myofibrillar pellet (obtained after the 600g spin) was washed with water (25ml per gram of fresh muscle) to release soluble and mitochondrial impurities. Myofibrillar proteins within the pellet were subsequently solubilized in 0.6 mol/l potassium chloride [16] (25ml per gram of fresh muscle) with the aid of an OMNI 1000 Polytron. The resulting suspension was centrifuged for 10min at 33000g. The resulting supernatant contained mainly dissolved actin and myosin.
The yield of the mitochondrial purification was about 20%. No proteolytic enzymes were used and, therefore, the preparations contained predominantly subsarcolemmal mitochondria. The intra-assay coefficient of variation of the mitochondrial protein content measurements was 4.4% (n = 6).
The purity of the mitochondrial fraction was checked in a separate experiment, in which the contamination by non-mitochondria1 ATPasecontaining structures was measured as previously described [17] .
Mitochondrial protein content in muscle
Zymosan-treated (n = 6), pair-fed (n = 6) and ad libitum-fed rats (n = 6) were killed by cervical dislocation 2 days after treatment. Combined hindquarter muscle was dissected, immediately frozen in liquid nitrogen using a precooled pair of tongs and stored at -80°C. Mitochondria were purified from muscle as described above and both the whole-muscle homogenate and the mitochondrial pellet were analysed for cytochrome c oxidase activity and protein content. Using the tissue and mitochondrial cytochrome c oxidase activities, mitochondrial protein content was calculated (tissue activity/mitochondrial activity).
Morphology of muscle mitochondria
Gastrocnemius muscle was obtained from zymosan-treated (n = 2), pair-fed (n = 2) and ad libitum-fed control (n = 2) rats. After dissection, portions of the muscle were immediately fixed in 2.5% Zymosan-treated (n = lo), pair-fed (n = 10) and ad libitum-fed rats (n = 8) were intraperitoneally injected with ~-[4-~H]phenylalanine (150 pmol/ml phenylalanine and 20 pCi/ml labelled phenylalanine; 2 ml/ lOOg body weight) as previously described [18] . Fifteen minutes later rats were killed by cervical dislocation and the hind limbs were transferred to ice-cold water. Subsequently, all hindquarter muscle was dissected, immediately frozen using a precooled pair of tongs in liquid nitrogen and stored at Muscle protein fractions were obtained as described above. During this procedure cycloheximide (0.5 mmol/l) was added to all buffers to arrest further incorporation of labelled phenylalanine during fractionation and analysis. Incorporation of C3H]phenylalanine into the different protein fractions was measured as previously described [19] . The perchloric acid supernatant of the mixed protein fraction was used to measure the specific activity of the precursor pool as previously described [ 191. This specific activity (SAprecursor) and the specific radioactivity of protein-bound phenylalanine (SAbound) of the different protein fractions were used to calculate fractional protein synthesis rates (FSRs):
As isotope equilibrium in the precursor pool is reached after 2-3 min in skeletal muscle, the time integral for the specific activity of the precursor is 0.9 of that which would have been obtained if the isotope equilibrium was instantaneous. The specific activity of the precursor was, therefore, multiplied by 0.9 as previously described [18] .
Mitochondrial protein content was measured as described above.
Analysis
Activities of cytochrome c oxidase were measured as previously described [20] using an adaptation of the method for a centrifugal analyser (Cobas Bio, Roche). Protein concentrations were measured using the Folin reagent method as described by Lowry et al. [21] .
Statistics
All measurements were performed in duplicate or triplicate except for the mitochondrial protein synthetic rate measurement (insufficient mitochondrial protein was available for duplicate analysis). Values are given as means (range). The Mann-Whitney Utest was used to determine statistically significant differences. Significance was set at P < 0.05.
RESULTS
The zymosan-injected rats responded in the same way as previously described [7] , as is reflected by the decreases in body weight and food intake in the zymosan-treated and pair-fed rats (Table 1) .
Mitochondrial protein content
No differences in the tissue activities of cytochrome c oxidase were observed 16h after treatment (Table 2) in combined hindquarter muscle. On day 2 the tissue activity was significantly reduced in zymosan-treated rats in comparison with both pairfed and ad libitum-fed control rats. Pair feeding significantly increased the tissue activity of cytochrome c oxidase. The pair-fed rats were allowed to eat as much as the zymosan-treated rats. Because of the approximately 95% decrease in food intake after zymosan treatment, the pair-fed control rats can be considered as semi-starved.
The mitochondrial activity of cytochrome c oxidase was increased in zymosan-treated rats 48h after treatment in comparison with both control groups ( Table 2 ). The mitochondrial protein content was significantly decreased in zymosan-treated rats on day 2 in comparison with pair-fed and ad libitum-fed control rats (Table 2 ). Pair feeding resulted in an increased mitochondrial protein content in combined hindquarter muscle.
Both the mitochondrial activity of cytochrome c oxidase and the mitochondrial protein content mea- were also observed. No such impairment was observed in muscle from either ad libitum-fed (Fig.  1) or pair-fed control rats (not shown).
Protein synthesis rates
The FSR of mixed protein from hindquarter muscle was decreased in zymosan-treated rats in comparison with both control groups ( Table 3 ). The FSR of mitochondrial protein was also decreased in zymosan-treated rats in comparison with both control groups. No significant difference was observed in the FSR of soluble protein in zymosantreated rats owing to a high coefficient of variation. The FSR of myofibrillar protein was also decreased in zymosan-challenged rats in comparison with pairfed and ad libitum-fed control rats. Pair feeding significantly decreased the FSR of all protein fractions to the same extent ( Table 3 ), indicating that part of the decrease in zymosan-treated rats was the result of starvation.
Absolute protein synthesis rates (mg protein synthesized per g muscle per day) were calculated for mixed and mitochondrial protein. In the zymosantreated rats absolute synthesis rates of both protein fractions were significantly decreased in comparison with pair-fed and ad libitum-fed control rats ( Table   4 ). In addition, pair feeding reduced these parameters significantly, although to a lesser extent than zymosan treatment. To obtain an estimate of the magnitude of the decrease in synthesis rates of mitochondrial protein in proportion to the decrease in mixed protein synthesis, absolute svnthesis rates of mitochondrial piotein were expressid as percentage of absolute synthesis rates of mixed protein of the decrease in mitochondrial protein synthesis in pair-fed rats is proportional to the decrease in mixed protein synthesis. In zymosan-treated rats, however, the lower percentage indicates that the decrease in mitochondrial protein synthesis was larger than that of mixed protein.
sured were similar to values obtained by Glatz and fractionation procedure was slightly modified in our study, a mitochondrial fraction with similar purity was obtained. In addition, the 92.5% inhibition of ATPase activities by oligomycin indicated minimal contamination of the mitochondrial fraction, similar to findings in other studies [17] .
Veerkamp
This indicates that, the skeletal muscle (Fig. 2) . These values indicated that
DISCUSSION

Mitochondrial morphology
Electron microscopic study of muscle morphology revealed swollen and disrupted mitochondria in some areas of the gastrocnemius muscle of Previously we reported that administration of zymosan-treated rats (Fig. 1) . Normal mitochondria zymosan to rats reduces the activity of two mitoprotein ?Significantly different from pair-fed control rats.
chondrial marker enzymes (citrate synthase and cytochrome c oxidase) in skeletal muscle, suggesting a decreased mitochondrial content [S]. In the present study we show that the decreased activities of these marker enzymes were the result of a decreased mitochondrial protein content and not of reduced enzyme activities in the mitochondria. Muscle mass was decreased in zymosan-treated rats in comparison with fed and pair-fed control groups, whereas the mixed protein content was not changed [7] . This implies that zymosan-treated rats have smaller muscles with a reduced content of mitochondria. Although activities of citrate synthase have been reported to be unchanged in skeletal muscle from moderately catabolic patients studied after elective surgery [22] , activities of cytochrome c oxidase were dramatically decreased in skeletal muscle from critically ill patients with septic complications [6] . This indicates that in critically ill patients also the characteristic wasting of muscle protein may be accompanied by an even more dramatic loss of mitochondrial protein.
Derangements in function and morphology of skeletal muscle mitochondria have previously been reported in response to a catabolic challenge, but to our knowledge no reports on a decreased mitochondrial content have appeared. Muscle mitochondrial respiratory control ratio has been reported to be either decreased [23-251 or unchanged [26] in septic rats. Morphological changes in skeletal muscle mitochondria in endotoxin-injected [23] and zymosan-treated rats included membrane distortion and mitochondrial swelling. Both a decreased mitochondrial content and an impaired mitochondrial function may result in a decreased muscle function. Exercise physiology studies have indicated that muscle endurance performance is clearly related to total mitochondrial density or activity [4] . A decreased mitochondrial content will be reflected in a reduced endurance capacity because maintenance of muscle ATP levels is compromised at much lower work rates and anaerobic glycolysis takes over as a primary energy source [27] . Consequently, both an impaired mitochondrial function and a decreased mitochondrial content could play a role in the weakness and rapid fatiguability that is experienced by critically ill and recovering patients.
Mitochondrial protein synthesis
Mitochondrial proteins are synthesized partly in the cytosol and inside the mitochondria. About 10% or less of the mitochondrial proteins is synthesized inside the mitochondria, including subunits of cytochrome reductase, cytochrome c oxidase and ATPase [ZS, 291. We assumed that the synthesis rate of mitochondrial protein, as measured in the present study, is that of all mitochondrial protein regardless of its genomic origin. The advantage of the in uiuo measurements over in uitro protein synthesis rate is that the average synthesis rates of all mitochondrial proteins is measured, whereas in uitro measurements reflect synthesis rates only of the few mitochondrial proteins encoded by the mitochondrial DNA. In control rats in uiuo FSRs of muscle mitochondria were 40% higher than those of mixed protein. The contribution of mitochondrial protein synthesis to mixed protein synthesis in skeletal muscle was 8%. Heart mitochondrial FSRs, also measured using the phenylalanine flooding dose technique, have been reported to be lower than those of mixed protein [29] . However, the contribution to mixed protein synthesis (20%) was much higher than in muscle owing to a substantially higher mitochondrial content in heart muscle.
The decreased mitochondrial protein content in skeletal muscle from zymosan-treated rats is at least in part the result of reduced synthesis of mitochondrial protein. Zymosan treatment decreased mitochondrial protein synthesis rates by 48% in comparison with the fed control rats. We cannot exclude the possibility that, in addition to the observed reduction in protein synthesis, enhanced breakdown of mitochondrial protein also contributes to the loss of mitochondrial protein. It has been suggested that during haemorrhage and endotoxaemia a release of lysosomal enzymes is involved in mitochondrial damage in liver The increased activity of cytochrome c oxidase in skeletal muscle from the pair-fed rats in combination with the decreased synthesis rates of mitochondrial protein indicate that the breakdown of mitochondrial protein is also inhibited by starvation. In the zymosan-treated rats the decreased synthesis rates of mitochondrial protein is most likely accompanied by increased breakdown rates.
Zymosan treatment reduced the FSRs of mixed protein in hindquarter muscle to 61% of control values. This is similar to the decrease previously measured in gastrocnemius muscle from zymosantreated rats [7] . The FSRs of both mitochondrial and myofibrillar proteins were decreased in zymosan-treated rats to approximately 50% of control values. The rates of synthesis of all protein fractions in the pair-fed rats decreased to about 75% of control values, indicating that only part of these decreases in zymosan-treated rats was the result of a decreased food intake. Myofibrillar protein accounts for a much larger portion of the mixed protein in skeletal muscle than does mitochondrial protein. Thus, it is likely that the decrease in the synthesis rates of mixed muscle protein in zymosan-treated rats is predominantly caused by the decreased synthesis of myofibrillar protein. Others have reported that surgical trauma decreases the FSRs of mixed, soluble and myofibrillar proteins in skeletal muscle [34] . Burn trauma has been reported to increase the FSRs of the three protein fractions in rat skeletal muscle [34] .
The decreased synthesis rates of mixed protein in skeletal muscle from zymosan-treated rats may be in part the result of a reduced activity. Zymosan treatment induced lethargy and consequently reduced activity in this and other studies [7, 111 . Inactivity induced by either immobilization or denervation of the leg have been reported to result in an early decrease in mixed protein synthesis rates in rat skeletal muscle [35-371. Reduced activity may also reduce mitochondrial content and mitochondrial enzyme activities. However, denervation experiments [38, 391 have suggested that mitochondrial enzyme activities decrease only after prolonged inactivation (over 6 days of denervation). As the mitochondrial content and synthesis rates of mitochondrial protein in the zymosan-treated rats decrease within 2 days after treatment, these changes are unlikely to be the result of reduced activity.
In the present study a decreased mitochondrial content and abnormal morphology were observed in skeletal muscle from zymosan-challenged rats. These features may provide a plausible mechanism for the muscle weakness and rapid fatiguability observed after a catabolic challenge (inflammation, trauma). The reduced mitochondrial content is at least in part the result of decreased rates of synthesis of mitochondrial protein.
